Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-79
SponsorAhmed A. Rahim

About this trial

Associative Peripheral Stimulation (APS) is a non-invasive therapy intended for stroke rehabilitation involving transcutaneous electrical muscle stimulation paired with voluntary movement. This pilot study investigates whether APS applied during the acute phase of stroke recovery may reduce impairment and improve function in the affected upper extremity.

Eligibility criteria

Qualifiers

Confirmed ischemic or hemorrhagic stroke no earlier than 7 days prior to enrollment;

Presentation of hemiparesis or paralysis of the upper extremity due to stroke;

Ability to comprehend and follow study instructions;

Ability to initiate finger extension (≥3°) at least three times per minute;

Disqualifiers

Contraindications, intolerance, or high sensitivity to the experimental protocol;

History of upper-extremity disability prior to the index stroke;

Neurological conditions (other than stroke) affecting motor function;

Treatment of spasticity/increased tone in the affected upper extremity (e.g., with Botox injection);

Trial design

Treatments tested in this trial

  • Associative Peripheral Stimulation (APS) 1.0
  • Peripheral Neuromuscular Stimulation

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ahmed A. Rahim

Lead sponsor

APS Trial Group

Sponsor institution